Assignee
AKSTON BIOSCIENCES CORP
US·22 granted patents·4 pending applications·153 citations·filing 2017–2025
Top patents by PatentIndex Score
26 records- 0198US12454565B2PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of useAKSTON BIOSCIENCES CORP·Filed 2025·Granted Oct 28, 2025·1 cites·20 claims
- 0298US11192930B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Dec 7, 2021·5 cites·7 claims
- 0398US10961294B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 30, 2021·24 cites·22 claims
- 0498US10947292B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 16, 2021·23 cites·21 claims
- 0598US10870686B2Ultra-long acting insulin-FC fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Dec 22, 2020·23 cites·21 claims
- 0698US10851147B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Dec 1, 2020·23 cites·21 claims
- 0797US11673934B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jun 13, 2023·2 cites·20 claims
- 0897US11186623B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Nov 30, 2021·6 cites·20 claims
- 0996US11919935B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Mar 5, 2024·2 cites·14 claims
- 1096US11814418B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Nov 14, 2023·2 cites·14 claims
- 1196US11773151B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Oct 3, 2023·2 cites·15 claims
- 1296US11261229B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 1, 2022·3 cites·14 claims
- 1395US11213581B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 4, 2022·3 cites·27 claims
- 1495US10597435B2Insulin-Fc fusions and methods of useAKSTON BIOSCIENCES CORP·Filed 2019·Granted Mar 24, 2020·21 cites·17 claims
- 1594US11267862B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 8, 2022·3 cites·14 claims
- 1694US11198719B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Dec 14, 2021·2 cites·3 claims
- 1788US2024101635A1Ultra-long acting insulin-fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 1887US11359001B2Insulin-Fc fusions and methods of useAKSTON BIOSCIENCES CORP·Filed 2017·Granted Jun 14, 2022·7 cites·19 claims
- 1987US11352407B2Ultra-long acting insulin-Fc fusion proteinsAKSTON BIOSCIENCES CORP·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 2081US2024182539A1Ultra-long acting insulin-fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2024·Application pending·0 cites
- 2177US2026035433A1Pd-l1 analog fusion proteins for antigen specific immunotherapy and methods of useAKSTON BIOSCIENCES CORP·Filed 2025·Application pending·0 cites
- 2276US11707517B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jul 25, 2023·0 cites·16 claims
- 2373US2023272031A1Insulin-fc fusion proteins and methods of use to treat cancerAKSTON BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 2472US12195511B2Ultra-long acting insulin-Fc fusion proteinAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 14, 2025·0 cites·24 claims
- 2571US11667689B2Insulin-Fc fusion proteins and methods of use to treat cancerAKSTON BIOSCIENCES CORP·Filed 2022·Granted Jun 6, 2023·0 cites·13 claims
- 2668US11555058B2Cells engineered to express ultra-long acting insulin-Fc fusion proteinsAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 17, 2023·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when AKSTON BIOSCIENCES CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →